Matches in Nanopublications for { ?s ?p "[In summary, this work provides the first in vivo evidence that administering BMMSCs or UCMSCs to rats with CLP-induced sepsis could increase circulating CD3+CD4+CD25+ Treg cells and Treg cells/T cells ratio, enhance Treg cell suppressive function, and decrease serum levels of interleukin-6 and tumor necrosis factor-?, suggesting the immunomodulatory association of Treg cells and MSCs during sepsis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[In summary, this work provides the first in vivo evidence that administering BMMSCs or UCMSCs to rats with CLP-induced sepsis could increase circulating CD3+CD4+CD25+ Treg cells and Treg cells/T cells ratio, enhance Treg cell suppressive function, and decrease serum levels of interleukin-6 and tumor necrosis factor-?, suggesting the immunomodulatory association of Treg cells and MSCs during sepsis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In summary, this work provides the first in vivo evidence that administering BMMSCs or UCMSCs to rats with CLP-induced sepsis could increase circulating CD3+CD4+CD25+ Treg cells and Treg cells/T cells ratio, enhance Treg cell suppressive function, and decrease serum levels of interleukin-6 and tumor necrosis factor-?, suggesting the immunomodulatory association of Treg cells and MSCs during sepsis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In summary, this work provides the first in vivo evidence that administering BMMSCs or UCMSCs to rats with CLP-induced sepsis could increase circulating CD3+CD4+CD25+ Treg cells and Treg cells/T cells ratio, enhance Treg cell suppressive function, and decrease serum levels of interleukin-6 and tumor necrosis factor-?, suggesting the immunomodulatory association of Treg cells and MSCs during sepsis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In summary, this work provides the first in vivo evidence that administering BMMSCs or UCMSCs to rats with CLP-induced sepsis could increase circulating CD3+CD4+CD25+ Treg cells and Treg cells/T cells ratio, enhance Treg cell suppressive function, and decrease serum levels of interleukin-6 and tumor necrosis factor-?, suggesting the immunomodulatory association of Treg cells and MSCs during sepsis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1231672.RAUwm4oynugLbYCJfnJuAM4q8ZFnuomHQ9K7ybTC0pgok130_assertion description "[In summary, this work provides the first in vivo evidence that administering BMMSCs or UCMSCs to rats with CLP-induced sepsis could increase circulating CD3+CD4+CD25+ Treg cells and Treg cells/T cells ratio, enhance Treg cell suppressive function, and decrease serum levels of interleukin-6 and tumor necrosis factor-?, suggesting the immunomodulatory association of Treg cells and MSCs during sepsis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231672.RAUwm4oynugLbYCJfnJuAM4q8ZFnuomHQ9K7ybTC0pgok130_provenance.
- NP1231679.RAYGXpWauWtJnpympp8M-2zPfgOrprqLB_NDm1dH73NsI130_assertion description "[In summary, this work provides the first in vivo evidence that administering BMMSCs or UCMSCs to rats with CLP-induced sepsis could increase circulating CD3+CD4+CD25+ Treg cells and Treg cells/T cells ratio, enhance Treg cell suppressive function, and decrease serum levels of interleukin-6 and tumor necrosis factor-?, suggesting the immunomodulatory association of Treg cells and MSCs during sepsis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231679.RAYGXpWauWtJnpympp8M-2zPfgOrprqLB_NDm1dH73NsI130_provenance.
- NP1231675.RAkPb7mQ5-BLJm5l_ZbnOsGeraOPtx358mzukEOUsfBEg130_assertion description "[In summary, this work provides the first in vivo evidence that administering BMMSCs or UCMSCs to rats with CLP-induced sepsis could increase circulating CD3+CD4+CD25+ Treg cells and Treg cells/T cells ratio, enhance Treg cell suppressive function, and decrease serum levels of interleukin-6 and tumor necrosis factor-?, suggesting the immunomodulatory association of Treg cells and MSCs during sepsis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231675.RAkPb7mQ5-BLJm5l_ZbnOsGeraOPtx358mzukEOUsfBEg130_provenance.
- NP1231677.RAlV5Jt8EdQrOqW79WThRnAIQSMW8GPuDIZkp7dLNvn0g130_assertion description "[In summary, this work provides the first in vivo evidence that administering BMMSCs or UCMSCs to rats with CLP-induced sepsis could increase circulating CD3+CD4+CD25+ Treg cells and Treg cells/T cells ratio, enhance Treg cell suppressive function, and decrease serum levels of interleukin-6 and tumor necrosis factor-?, suggesting the immunomodulatory association of Treg cells and MSCs during sepsis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231677.RAlV5Jt8EdQrOqW79WThRnAIQSMW8GPuDIZkp7dLNvn0g130_provenance.